Ligand-induced genetic degradation as a tool for target validation

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Targeted protein degraders, such as proteolysis targeting chimeras (PROTACs), are emerging as a powerful therapeutic strategy.
• Many proteins remain undruggable with conventional methods, highlighting the need for novel approaches.
• Developing effective degraders is a complex, time-consuming, and expensive process.

Purpose of the Study:

• To introduce ligand-induced genetic degradation systems as a method for validating candidate proteins prior to degrader development.
• To provide a comprehensive review of existing genetic degradation systems.
• To propose a strategic framework for discovering degraders against novel protein targets.

Main Methods:

• Review of genetic degradation systems including dTAG, HaloTag-based, auxin-inducible degron (AID), and destabilizing domain (DD).
• Explanation of the mechanism of genetic degradation: fusion of a degron to a protein of interest, recruitment to an E3 ubiquitin ligase, and proteasomal degradation.
• Discussion of the principles and features differentiating these genetic systems.

Main Results:

• Genetic degradation systems effectively mimic the depletion of target proteins achieved by degrader treatment.
• These systems utilize a degron and a specific ligand to induce protein degradation via the ubiquitin-proteasome pathway.
• Different genetic systems (dTAG, HaloTag, AID, DD) operate on distinct principles and possess unique characteristics.

Conclusions:

• Ligand-induced genetic degradation serves as a valuable tool for validating therapeutic targets and de-risking drug discovery pipelines.
• Understanding the mechanisms and features of various genetic degradation systems is crucial for their optimal application.
• This approach facilitates the development of targeted protein degraders for previously undruggable proteins, advancing next-generation therapeutics.